Ling Shen

Breast cancer cell-free DNA (cfDNA) profiles reflect underlying tumor biology: The Circulating Cell-Free Genome Atlas (CCGA) study.

F. Couch, E. Hubbell, Anton Valouev, 2018 .

Genome-wide sequencing for early stage lung cancer detection from plasma cell-free DNA (cfDNA): The Circulating Cancer Genome Atlas (CCGA) study.

S. Plevritis, E. Hubbell, Anton Valouev, 2018, Journal of Clinical Oncology.

Cell-free DNA (cfDNA) mutations from clonal hematopoiesis: Implications for interpretation of liquid biopsy tests.

M. Berger, E. Hubbell, J. Reis-Filho, 2017 .

Development of a comprehensive cell-free DNA (cfDNA) assay for early detection of multiple tumor types: The Circulating Cell-free Genome Atlas (CCGA) study.

R. Tibshirani, T. Yeatman, E. Hubbell, 2018 .

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

David R. Jones, M. Ladanyi, E. Hubbell, 2019, Nature Medicine.

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

M. Ladanyi, E. Hubbell, C. Rudin, 2019, Nature Medicine.

Prevalence of clonal hematopoiesis of indeterminate potential (CHIP) measured by an ultra-sensitive sequencing assay: Exploratory analysis of the Circulating Cancer Genome Atlas (CCGA) study.

T. Yeatman, E. Hubbell, Anton Valouev, 2018 .

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

D. Berry, S. Cummings, E. Fung, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.